Sat, Oct 25, 2014, 7:21 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Navidea Biopharmaceuticals, Inc Message Board

  • hoopsrh hoopsrh May 17, 2013 7:27 PM Flag

    Medical Marketing & Media Article

    The launch also includes dinner meetings, as well as traditional live and web-based CME. Navidea is working with an accredited provider, which the company declined to name. Several of its papers were accepted for presentation at the Joint International Oncology Congress this month and at the Society of Nuclear Medicine & Molecular Imaging annual meeting, which is being held in June.

    Tulip said the MSL approach “lets us leverage what we learn in the clinic and pharmacy and apply it to not only educate customers to drive adoption [but] also to lift the overall top-line to make the market grow.”
    He said Navidea's long-term goal involves expanding Lymphoseek's market from breast cancer and melanoma to other cancer types that lend themselves to lymphatic mapping, such as colorectal, gastric, and head and neck, where a sNDA is planned for this year. “The mechanism of action is not cancer-specific,” added Tulip, but may apply to “any solid tumor that drains into the lymphatics.”

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
NAVB
1.36-0.04(-2.86%)Oct 24 4:03 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Cabela's Incorporated
NYSEFri, Oct 24, 2014 4:00 PM EDT